Reducing Distress in Phase 1 Trial Caregivers: The P1-CaLL Study

NCT ID: NCT03557515

Last Updated: 2021-05-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-12

Study Completion Date

2021-05-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study seeks to decrease distress in the lives of the caregivers who are helping cancer patients who have entered a phase 1 clinical trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study seeks to decrease distress in the lives of the caregivers who are helping cancer patients who have entered a phase 1 clinical trial. The P1-CaLL study uses a psychosocial intervention aimed at decreasing distress through the utilization of adaptive coping strategies (e.g., meditation, emotion-focused coping) and cognitive behavioral techniques. Caregivers will receive 4 weeks of stress-management sessions (over the phone). Then, they will be randomized to receive 4 more weekly sessions of either Cognitive Behavioral Therapy or Metta-Meditation (over the phone). Participants will receive tasks to complete each week.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caregiver Distress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CBT Telephonic Sessions

All participants will receive four stress management sessions. Then, the participant is randomly assigned to receive 4 weekly additional CBT telephonic sessions. Participants will be given weekly assignments to practice the skills learned in the sessions. Sessions will last 45 minutes to 1 hour. Optional grief and loss telephonic session will be offered.

Group Type EXPERIMENTAL

Stress Management and CBT

Intervention Type BEHAVIORAL

Stress Management will focus on:

1. Mind-Body Connection
2. Coping Skills
3. Communication
4. Social Support

Cognitive Behavioral Therapy will focus on:

1. Intro to CBT-Tracking Automatic Thoughts
2. Identifying Distorted Thoughts
3. Challenging Distorted Thoughts
4. Core Beliefs/Relapse Prevention

Metta-Meditation Telephonic Sessions

All participants will receive four stress management sessions. Then, the participant is randomly assigned to receive 4 weekly additional Metta-meditation sessions. Participants will be given weekly assignments to practice the skills learned in the sessions. Sessions will last 45 minutes to 1 hour. Optional grief and loss telephonic session will be offered.

Group Type EXPERIMENTAL

Stress Management and Metta-Meditation

Intervention Type BEHAVIORAL

Stress Management will focus on:

1. Mind-Body Connection
2. Coping Skills
3. Communication
4. Social Support

Metta-Meditation will focus on:

1. Intro to Meditation vis Mindfulness of the Breath and Body-Noticing Critical Self Talk
2. Intro to Brief Loving-Kindness Meditation and Self-Care
3. Continuing with Additional Metta-Based Exercises to Cultivate Compassion for Oneself and Others and Mitigating Self-Criticism
4. Review/Plan for Future

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stress Management and CBT

Stress Management will focus on:

1. Mind-Body Connection
2. Coping Skills
3. Communication
4. Social Support

Cognitive Behavioral Therapy will focus on:

1. Intro to CBT-Tracking Automatic Thoughts
2. Identifying Distorted Thoughts
3. Challenging Distorted Thoughts
4. Core Beliefs/Relapse Prevention

Intervention Type BEHAVIORAL

Stress Management and Metta-Meditation

Stress Management will focus on:

1. Mind-Body Connection
2. Coping Skills
3. Communication
4. Social Support

Metta-Meditation will focus on:

1. Intro to Meditation vis Mindfulness of the Breath and Body-Noticing Critical Self Talk
2. Intro to Brief Loving-Kindness Meditation and Self-Care
3. Continuing with Additional Metta-Based Exercises to Cultivate Compassion for Oneself and Others and Mitigating Self-Criticism
4. Review/Plan for Future

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Informal caregiver of a patient screening for a phase 1 clinical trial
2. Self-identifies as a caregiver as consistent with the National Study Of Caregiving (NSOC) definition13- individuals who help a patient with self-care, mobility, or household activities (the latter, for health or functioning related reasons) and are either related to the patient (paid or and non-paid) or are unrelated non-paid helpers.
3. Provision to sign and date the consent form.
4. Completes the Patient Health Questionnaire (PHQ-4) screener with a total score of \>3.
5. Stated willingness to comply with all study procedures and be available for the duration of the study.
6. Age \>18
7. Has consistent access to a telephone
8. Able to read and understand English

Exclusion Criteria

1. Has a cognitive or psychiatric condition prohibiting participation.
2. Current enrollment in another psychosocial intervention trial.
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Colorado, Denver

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kristin Kilbourn, MD

Role: PRINCIPAL_INVESTIGATOR

University of Colorado, Denver

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universtiy of Colorado Denver

Denver, Colorado, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-0514.cc

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CALM Phase 2b Pilot
NCT02353546 COMPLETED NA